Neutrophils as emerging therapeutic targets

Area of Science:

• Immunology
• Cell Biology
• Pathology

Background:

• Neutrophils are the most abundant leukocytes, crucial for innate immunity against bacterial and fungal pathogens.
• Paradoxically, neutrophils also contribute to tissue damage in autoimmune diseases, inflammation, and cancer progression.
• Their complex roles necessitate careful consideration for therapeutic interventions.

Purpose of the Study:

• To review current therapeutic strategies targeting neutrophils.
• To highlight the challenges and controversies in modulating neutrophil function for disease treatment.
• To provide an overview of agents in clinical trials.

Main Methods:

• Literature review of therapeutic approaches targeting neutrophils.
• Analysis of strategies to enhance, inhibit, or restore neutrophil function.
• Discussion of clinical trial progress and remaining challenges.

Main Results:

• Multiple therapeutic strategies for neutrophils are under investigation.
• Several neutrophil-targeting agents have advanced to clinical trials.
• Significant challenges and ongoing controversies exist in the field.

Conclusions:

• Neutrophil-targeted therapies hold promise but require careful navigation of their dual roles.
• Further research is needed to overcome existing challenges and optimize therapeutic outcomes.
• Differentiating beneficial from detrimental neutrophil responses is critical for effective treatment.